For several decades, endometriosis has been suspected of playing a role in the aetiology of
ovarian cancer. The literature concerning a possible histogenesis of ovarian cancer from …

Ovarian cancer accounts for 4% of all cancers in women and is the leading cause of death
from gynaecologic malignancies. Because early-stage ovarian cancer is generally …

Introduction Many national guidelines concerning the management of ovarian cancer
currently advocate the risk of malignancy index (RMI) to characterise ovarian pathology …

METHODS Patients with stage III-IV high-grade ovarian cancer undergoing surgical
cytoreduction (R0/complete resection permitted) and responding to first-line platinum …

Background: Recently, a Risk of Ovarian Malignancy Algorithm (ROMA) utilising human
epididymis secretory protein 4 (HE4) and CA125 successfully classified patients as …

Over the last decades, the management of borderline ovarian tumors (BOTs) has changed
from radical surgery to more conservative therapy as a result of the need for fertility-sparing …

Background Mirvetuximab soravtansine-gynx (MIRV), a first-in-class antibody–drug
conjugate targeting folate receptor α (FRα), is approved for the treatment of platinum …

OBJECTIVES: The purpose of this review is to determine the incidence of lymph node
metastases in clinical stages I and II ovarian cancer. METHODS: Relevant articles were …

Approximately 80% of patients with ovarian cancer experience recurrence after platinum-
based chemotherapy, and unfortunately nearly all will eventually develop platinum-resistant …

Design for Emotion introduces you to the why, what, when, where and how of designing for
emotion. Improve user connection, satisfaction and loyalty by incorporating emotion and …